{
    "document_id": "D-2023-2357",
    "LinkTitle": "D-2023-2357",
    "file_name": "D-2023-2357.pdf",
    "file_path": "/Users/JADEPOTTER5/Downloads/DMP-MT/processed_data/pdfs_new/org_pdfs/D-2023-2357.pdf",
    "metadata": {
        "title": "2PROLONG: better preservation and early outcome prediction of donor kidneys",
        "author": "N/A",
        "num_pages": 7
    },
    "content": {
        "full_text": "2PROLONG: better preservation and early outcome prediction of donor kidneys\n2PROLONG: better preservation and early outcome prediction of donor kidneys\nA Data Management Plan created using DMPonline.be\nCreator: \nCreator: \nIna Jochmans\nAffiliation: \nAffiliation: \nKU Leuven (KUL)\nTemplate: \nTemplate: \nKU Leuven BOF-IOF\nPrincipal Investigator:\nPrincipal Investigator:\n \nIna Jochmans\nGrant number / URL: \nGrant number / URL: \nC2M/23/051\nID: \nID: \n202393\nStart date: \nStart date: \n01-10-2023\nEnd date: \nEnd date: \n30-09-2027\nProject abstract:\nProject abstract:\nKidney transplantation is hampered by organ shortage. Too many donor kidneys are not transplanted because (1) safe prolonged preservation is not\npossible, (2) no reliable tools for pre-transplant viability assessment exist, (3) ischemia- reperfusion injury cannot be treated.\n2PROLONG will tackle these unmet needs by further developing kidney perfusion as a preservation and viability assessment platform. Nutrient\nmetabolism during kidney perfusion is central in this project.\nIn Part 1, we will design a preservation solution that supports the nutritional needs of the kidneys during cold kidney perfusion, supporting\npreservation for up to 3 days.\nIn Part 2, we will pioneer whole organ spatial localisation of nutrient consumption in the kidney which will in future lead to the discovery of novel\nmetabolic targets to prevent or treat ischemia reperfusion injury.\nIn Part 3, we will validate our viability biomarkers identified during warm perfusion of pig kidneys in 2 human transplant cohorts.\nLast modified: \nLast modified: \n12-06-2024\nCreated using DMPonline.be. Last modiﬁed 12 June 2024\n1 of 7\n2PROLONG: better preservation and early outcome prediction of donor kidneys\n2PROLONG: better preservation and early outcome prediction of donor kidneys\nResearch Data Summary\nResearch Data Summary\nList and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or\nList and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or\ndata type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate\ndata type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate\nwhether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its\nwhether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its\ntechnical format (file extension), and an estimate of the upper limit of the volume of the data.\ntechnical format (file extension), and an estimate of the upper limit of the volume of the data.\nDataset name / ID\nDescription\nNew or reuse\nDigital or\nPhysical data\nData Type\nFile\nformat\nData\nvolume\nPhysical\nvolume\n \n \nIndicate:\nN\nN\n(ew data) or\nE\nE\n(xisting data) \nIndicate: \nD\nD\n(igital) or\nP\nP\n(hysical)\nIndicate:\nA\nA\nudiovisual\nI\nI\nmages\nS\nS\nound\nN\nN\numerical\nT\nT\nextual\nM\nM\nodel\nSO\nSO\nftware\nOther\n(specify)\n \nIndicate:\n<1GB\n<100GB\n<1TB\n<5TB\n>5TB\nNA\n \nDonor data\nData of organ donor (animal/human)\nN\nP and D\nN, T and I\n.xlsx\n.jpg\n.tiff\n<1GB\n2 to 3 A4\npages per\nexperiment\nPerfusion parameters\nPerfusion parameters (pressure, flow,\ntemperature, pO2,...)\nN\nD\nN\n.xlsx\n.html\n<1GB\n \nBiochemical markers\nMarkers measured in LAG and ABG\nN\nD and P\nN\n.xlsx\n.html\n<1GB\n1 to 2 A4\npages per\nexperiment\nProtein analysis\nELISA\nN\nD\nN\n.xlsx\n<1GB\n \nMetabolomics \nMass spectrometry data\nN\nD\nN\n.mzML\n.xlsx\n>5TB\n \nImaging mass\nspectrometry\nImaging mass spectrometry\nN\nD\nI and N\n.mzML\n.xlsx\n.jpg\n.tiff\n>5TB\n \nHistology\nTissue slices; Image files from\nmicroscopes; Semi-quantitative scoring\nN\nD\nN, I and T\n.xlsx\n.jpg\n.tiff\n<1TB\n1 to 5 slides\nper\nexperiment\nData analysis and\nmanuscript preparation\n \nN\nD\nN, I and T\n.xlxs\n.docx\n.jpg\n.tiff\n.pdf\n.pzfx\n<100GB\n \nIf you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data\nIf you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data\ntype:\ntype:\nData from previous animal experiments might be reused (doi.org/10.48804/MAQMAE and doi.org/10.21228/M89Q7K)).\nAre there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If so, refer to\nAre there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If so, refer to\nspecific datasets or data types when appropriate and provide the relevant ethical approval number.\nspecific datasets or data types when appropriate and provide the relevant ethical approval number.\nCreated using DMPonline.be. Last modiﬁed 12 June 2024\n2 of 7\nYes, human subject data (Provide SMEC or EC approval number below)\nYes, animal data (Provide ECD reference number below)\nAnimal experiments of Part 1: P061/2022\nAnimal experiments of Part 2: pending\nPart 3: UZ Leuven Ethics committee (approved s66539)\n \nWill you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven or UZ\nWill you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven or UZ\nLeuven privacy register number (G or S number).\nLeuven privacy register number (G or S number).\nYes (Provide PRET G-number or EC S-number below)\nUZ Leuven Ethics committee (approved s66539)\nDoes your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)?  If so,\nDoes your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)?  If so,\nplease comment per dataset or data type where appropriate. \nplease comment per dataset or data type where appropriate. \nYes\nIf data obtained is of interest for valorization, IP restriction will be claimed. It is not clear from the start what novel relevant markers could be\nidentified or what type of perfusion fluid will be developed.\nDo existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer agreements,\nDo existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer agreements,\nResearch collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place.\nResearch collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place.\nYes\nIn Part 3 we will analyse samples from transplanted kidneys from Rotterdam, the Netherlands. Data related to the transplant procedures will\nalso be provide. \nAn MTA and DTA has been signed for these experiments. We will share data where possible.\nAre there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please\nAre there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please\nexplain in the comment section to what data they relate and which restrictions will be asserted.\nexplain in the comment section to what data they relate and which restrictions will be asserted.\nNo\nDocumentation and Metadata\nDocumentation and Metadata\nClearly describe what approach will be followed to capture the accompanying information necessary to keep \nClearly describe what approach will be followed to capture the accompanying information necessary to keep \ndata understandable and usable\ndata understandable and usable\n,\n,\nfor yourself and others, now and in the future (e.g. in terms of documentation levels and types required, procedures used, Electronic Lab\nfor yourself and others, now and in the future (e.g. in terms of documentation levels and types required, procedures used, Electronic Lab\nNotebooks, README.txt files, codebook.tsv etc. where this information is recorded). \nNotebooks, README.txt files, codebook.tsv etc. where this information is recorded). \nData management is provided in either Onenote (used as ELN), Onedrive, or hard copy lab notebooks. We also document in Excel\nspreadsheets and Word.\nOther lab members will have access to the data for the entire duration of the specific project. We guarantee handover of data to the PI upon\ndeparture of the involved PhD/postdocs.\nWe will provide all necessary details that will help others to find the data, including who created or contributed to the data, the title of the\ndataset, and the date of creation. We will provide supplementary materials to peer-reviewed manuscripts to increase the transfer of all details.\nCreated using DMPonline.be. Last modiﬁed 12 June 2024\n3 of 7\nDocumentation will also include details on the methodology used, analytical and procedural information, definitions of variables, vocabularies,\nunits of measurement, and the format and the file type of the data.\nGenerated metabolomics data will be uploaded to NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the\nMetabolomics Workbench in combination with related metadata to be accessible to the public.\nBiochemical data generated in experiments will be uploaded to KU Leuven RDR in combination with related metadata to be accessible to the\npublic.\nWill a metadata standard be used to make it easier to \nWill a metadata standard be used to make it easier to \nfind and reuse the data\nfind and reuse the data\n?  \n?  \nIf so, please specify which metadata standard will be used. \nIf so, please specify which metadata standard will be used. \nIf not, please specify which metadata will be created to make the data easier to find and reuse. \nIf not, please specify which metadata will be created to make the data easier to find and reuse. \nYes\nFor metabolomics data, the metadata standards of NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the\nMetabolomics Workbench will be used.\nData Storage & Back-up during the Research Project\nData Storage & Back-up during the Research Project\nWhere will the data be stored?\nWhere will the data be stored?\nShared network drive (J-drive)\nOneDrive (KU Leuven)\nSharepoint online\nHow will the data be backed up?\nHow will the data be backed up?\nStandard back-up provided by KU Leuven ICTS for my storage solution\nIs there currently sufficient storage & backup capacity during the project? \nIs there currently sufficient storage & backup capacity during the project? \nIf no or insufficient storage or backup capacities are available, explain how this will be taken care of. \nIf no or insufficient storage or backup capacities are available, explain how this will be taken care of. \nYes\nHow will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? \nHow will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? \nAll data will be stored in the shared drive of KULeuven for which the access is managed by the lab manager. So access is only granted to\npeople involved in the project.\nWhat are the expected costs for data storage and backup during the research project? How will these costs be covered?\nWhat are the expected costs for data storage and backup during the research project? How will these costs be covered?\nThe costs are covered by the project and are in the range of 500 euro/year\nCreated using DMPonline.be. Last modiﬁed 12 June 2024\n4 of 7\nData Preservation after the end of the Research Project\nData Preservation after the end of the Research Project\nWhich data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of the project? \nWhich data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of the project? \nIn case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional\nIn case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional\npolicies...).\npolicies...).\nAll data will be preserved for 10 years according to KU Leuven RDM policy\nWhere will these data be archived (stored and curated for the long-term)? \nWhere will these data be archived (stored and curated for the long-term)? \nShared network drive (J-drive)\nKU Leuven RDR\nOther (specify below)\nLarge Volume Storage (longterm for large volumes)\nNIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench\nWhat are the expected costs for data preservation during the expected retention period? How will these costs be covered?\nWhat are the expected costs for data preservation during the expected retention period? How will these costs be covered?\n€51,9/100Gb/year\nThe costs are covered by project funding\nData Sharing and Reuse\nData Sharing and Reuse\nWill the data (or part of the data) be made available for reuse after/during the project?  \nWill the data (or part of the data) be made available for reuse after/during the project?  \nPlease explain per dataset or data type which data will be made available.\nPlease explain per dataset or data type which data will be made available.\nYes, as open data\nWith regard to human data, restrictions may apply.\nIf access is restricted, please specify who will be able to access the data and under what conditions. \nIf access is restricted, please specify who will be able to access the data and under what conditions. \nFor Part 3 MTA and DTA need to be followed.\nAre there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal\nAre there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal\nrestrictions)? \nrestrictions)? \nPlease explain per dataset or data type where appropriate.\nPlease explain per dataset or data type where appropriate.\nYes, privacy aspects\nYes, intellectual property rights\nYes, ethical aspects\nWhere will the data be made available?  \nWhere will the data be made available?  \nIf already known, please provide a repository per dataset or data type.\nIf already known, please provide a repository per dataset or data type.\nCreated using DMPonline.be. Last modiﬁed 12 June 2024\n5 of 7\nKU Leuven RDR (Research Data Repository)\nOther data repository (specify below)\nNIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench\nWhen will the data be made available? \nWhen will the data be made available? \nUpon publication of research results\nWhich data usage licenses are you going to provide? \nWhich data usage licenses are you going to provide? \nIf none, please explain why. \nIf none, please explain why. \nCC-BY 4.0 (data)\nData Transfer Agreement (restricted data)\nDo you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please provide it\nDo you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please provide it\nhere. \nhere. \n​​\nYes, a PID will be added upon deposit in a data repository\nWhat are the expected costs for data sharing? How will these costs be covered?  \nWhat are the expected costs for data sharing? How will these costs be covered?  \nOpen source storage without cost (NIH) or provided by KU Leuven services (RDR).\nResponsibilities\nResponsibilities\nWho will manage data documentation and metadata during the research project? \nWho will manage data documentation and metadata during the research project? \nThe PI is responsible for data documentation and metadata.\nWho will manage data storage and backup during the research project? \nWho will manage data storage and backup during the research project? \nData storage and backup is managed by the PI together with the lab manager.\nWho will manage data preservation and sharing? \nWho will manage data preservation and sharing? \nPI together with the lab manager.\nWho will update and implement this DMP? \nWho will update and implement this DMP? \nPI together with the lab manager.\nCreated using DMPonline.be. Last modiﬁed 12 June 2024\n6 of 7\nCreated using DMPonline.be. Last modiﬁed 12 June 2024\n7 of 7"
    },
    "clean_full_text": "2PROLONG: better preservation and early outcome prediction of donor kidneys 2PROLONG: better preservation and early outcome prediction of donor kidneys A Data Management Plan created using DMPonline.be Creator: Creator: Ina Jochmans Affiliation: Affiliation: KU Leuven (KUL) Template: Template: KU Leuven BOF-IOF Principal Investigator: Principal Investigator: Ina Jochmans Grant number / URL: Grant number / URL: C2M/23/051 ID: ID: 202393 Start date: Start date: 01-10-2023 End date: End date: 30-09-2027 Project abstract: Project abstract: Kidney transplantation is hampered by organ shortage. Too many donor kidneys are not transplanted because (1) safe prolonged preservation is not possible, (2) no reliable tools for pre-transplant viability assessment exist, (3) ischemia- reperfusion injury cannot be treated. 2PROLONG will tackle these unmet needs by further developing kidney perfusion as a preservation and viability assessment platform. Nutrient metabolism during kidney perfusion is central in this project. In Part 1, we will design a preservation solution that supports the nutritional needs of the kidneys during cold kidney perfusion, supporting preservation for up to 3 days. In Part 2, we will pioneer whole organ spatial localisation of nutrient consumption in the kidney which will in future lead to the discovery of novel metabolic targets to prevent or treat ischemia reperfusion injury. In Part 3, we will validate our viability biomarkers identified during warm perfusion of pig kidneys in 2 human transplant cohorts. Last modified: Last modified: 12-06-2024 Created using DMPonline.be. Last modiﬁed 12 June 2024 1 of 7 2PROLONG: better preservation and early outcome prediction of donor kidneys 2PROLONG: better preservation and early outcome prediction of donor kidneys Research Data Summary Research Data Summary List and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or List and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its whether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data. technical format (file extension), and an estimate of the upper limit of the volume of the data. Dataset name / ID Description New or reuse Digital or Physical data Data Type File format Data volume Physical volume Indicate: N N (ew data) or E E (xisting data) Indicate: D D (igital) or P P (hysical) Indicate: A A udiovisual I I mages S S ound N N umerical T T extual M M odel SO SO ftware Other (specify) Indicate: <1GB <100GB <1TB <5TB >5TB NA Donor data Data of organ donor (animal/human) N P and D N, T and I .xlsx .jpg .tiff <1GB 2 to 3 A4 pages per experiment Perfusion parameters Perfusion parameters (pressure, flow, temperature, pO2,...) N D N .xlsx .html <1GB Biochemical markers Markers measured in LAG and ABG N D and P N .xlsx .html <1GB 1 to 2 A4 pages per experiment Protein analysis ELISA N D N .xlsx <1GB Metabolomics Mass spectrometry data N D N .mzML .xlsx >5TB Imaging mass spectrometry Imaging mass spectrometry N D I and N .mzML .xlsx .jpg .tiff >5TB Histology Tissue slices; Image files from microscopes; Semi-quantitative scoring N D N, I and T .xlsx .jpg .tiff <1TB 1 to 5 slides per experiment Data analysis and manuscript preparation N D N, I and T .xlxs .docx .jpg .tiff .pdf .pzfx <100GB If you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data If you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data type: type: Data from previous animal experiments might be reused (doi.org/10.48804/MAQMAE and doi.org/10.21228/M89Q7K)). Are there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If so, refer to Are there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If so, refer to specific datasets or data types when appropriate and provide the relevant ethical approval number. specific datasets or data types when appropriate and provide the relevant ethical approval number. Created using DMPonline.be. Last modiﬁed 12 June 2024 2 of 7 Yes, human subject data (Provide SMEC or EC approval number below) Yes, animal data (Provide ECD reference number below) Animal experiments of Part 1: P061/2022 Animal experiments of Part 2: pending Part 3: UZ Leuven Ethics committee (approved s66539) Will you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven or UZ Will you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven or UZ Leuven privacy register number (G or S number). Leuven privacy register number (G or S number). Yes (Provide PRET G-number or EC S-number below) UZ Leuven Ethics committee (approved s66539) Does your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)? If so, Does your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)? If so, please comment per dataset or data type where appropriate. please comment per dataset or data type where appropriate. Yes If data obtained is of interest for valorization, IP restriction will be claimed. It is not clear from the start what novel relevant markers could be identified or what type of perfusion fluid will be developed. Do existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer agreements, Do existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer agreements, Research collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place. Research collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place. Yes In Part 3 we will analyse samples from transplanted kidneys from Rotterdam, the Netherlands. Data related to the transplant procedures will also be provide. An MTA and DTA has been signed for these experiments. We will share data where possible. Are there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please Are there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted. explain in the comment section to what data they relate and which restrictions will be asserted. No Documentation and Metadata Documentation and Metadata Clearly describe what approach will be followed to capture the accompanying information necessary to keep Clearly describe what approach will be followed to capture the accompanying information necessary to keep data understandable and usable data understandable and usable , , for yourself and others, now and in the future (e.g. in terms of documentation levels and types required, procedures used, Electronic Lab for yourself and others, now and in the future (e.g. in terms of documentation levels and types required, procedures used, Electronic Lab Notebooks, README.txt files, codebook.tsv etc. where this information is recorded). Notebooks, README.txt files, codebook.tsv etc. where this information is recorded). Data management is provided in either Onenote (used as ELN), Onedrive, or hard copy lab notebooks. We also document in Excel spreadsheets and Word. Other lab members will have access to the data for the entire duration of the specific project. We guarantee handover of data to the PI upon departure of the involved PhD/postdocs. We will provide all necessary details that will help others to find the data, including who created or contributed to the data, the title of the dataset, and the date of creation. We will provide supplementary materials to peer-reviewed manuscripts to increase the transfer of all details. Created using DMPonline.be. Last modiﬁed 12 June 2024 3 of 7 Documentation will also include details on the methodology used, analytical and procedural information, definitions of variables, vocabularies, units of measurement, and the format and the file type of the data. Generated metabolomics data will be uploaded to NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench in combination with related metadata to be accessible to the public. Biochemical data generated in experiments will be uploaded to KU Leuven RDR in combination with related metadata to be accessible to the public. Will a metadata standard be used to make it easier to Will a metadata standard be used to make it easier to find and reuse the data find and reuse the data ? ? If so, please specify which metadata standard will be used. If so, please specify which metadata standard will be used. If not, please specify which metadata will be created to make the data easier to find and reuse. If not, please specify which metadata will be created to make the data easier to find and reuse. Yes For metabolomics data, the metadata standards of NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench will be used. Data Storage & Back-up during the Research Project Data Storage & Back-up during the Research Project Where will the data be stored? Where will the data be stored? Shared network drive (J-drive) OneDrive (KU Leuven) Sharepoint online How will the data be backed up? How will the data be backed up? Standard back-up provided by KU Leuven ICTS for my storage solution Is there currently sufficient storage & backup capacity during the project? Is there currently sufficient storage & backup capacity during the project? If no or insufficient storage or backup capacities are available, explain how this will be taken care of. If no or insufficient storage or backup capacities are available, explain how this will be taken care of. Yes How will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? How will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? All data will be stored in the shared drive of KULeuven for which the access is managed by the lab manager. So access is only granted to people involved in the project. What are the expected costs for data storage and backup during the research project? How will these costs be covered? What are the expected costs for data storage and backup during the research project? How will these costs be covered? The costs are covered by the project and are in the range of 500 euro/year Created using DMPonline.be. Last modiﬁed 12 June 2024 4 of 7 Data Preservation after the end of the Research Project Data Preservation after the end of the Research Project Which data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of the project? Which data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of the project? In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional policies...). policies...). All data will be preserved for 10 years according to KU Leuven RDM policy Where will these data be archived (stored and curated for the long-term)? Where will these data be archived (stored and curated for the long-term)? Shared network drive (J-drive) KU Leuven RDR Other (specify below) Large Volume Storage (longterm for large volumes) NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench What are the expected costs for data preservation during the expected retention period? How will these costs be covered? What are the expected costs for data preservation during the expected retention period? How will these costs be covered? €51,9/100Gb/year The costs are covered by project funding Data Sharing and Reuse Data Sharing and Reuse Will the data (or part of the data) be made available for reuse after/during the project? Will the data (or part of the data) be made available for reuse after/during the project? Please explain per dataset or data type which data will be made available. Please explain per dataset or data type which data will be made available. Yes, as open data With regard to human data, restrictions may apply. If access is restricted, please specify who will be able to access the data and under what conditions. If access is restricted, please specify who will be able to access the data and under what conditions. For Part 3 MTA and DTA need to be followed. Are there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal Are there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal restrictions)? restrictions)? Please explain per dataset or data type where appropriate. Please explain per dataset or data type where appropriate. Yes, privacy aspects Yes, intellectual property rights Yes, ethical aspects Where will the data be made available? Where will the data be made available? If already known, please provide a repository per dataset or data type. If already known, please provide a repository per dataset or data type. Created using DMPonline.be. Last modiﬁed 12 June 2024 5 of 7 KU Leuven RDR (Research Data Repository) Other data repository (specify below) NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench When will the data be made available? When will the data be made available? Upon publication of research results Which data usage licenses are you going to provide? Which data usage licenses are you going to provide? If none, please explain why. If none, please explain why. CC-BY 4.0 (data) Data Transfer Agreement (restricted data) Do you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please provide it Do you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please provide it here. here. ​​ Yes, a PID will be added upon deposit in a data repository What are the expected costs for data sharing? How will these costs be covered? What are the expected costs for data sharing? How will these costs be covered? Open source storage without cost (NIH) or provided by KU Leuven services (RDR). Responsibilities Responsibilities Who will manage data documentation and metadata during the research project? Who will manage data documentation and metadata during the research project? The PI is responsible for data documentation and metadata. Who will manage data storage and backup during the research project? Who will manage data storage and backup during the research project? Data storage and backup is managed by the PI together with the lab manager. Who will manage data preservation and sharing? Who will manage data preservation and sharing? PI together with the lab manager. Who will update and implement this DMP? Who will update and implement this DMP? PI together with the lab manager. Created using DMPonline.be. Last modiﬁed 12 June 2024 6 of 7 Created using DMPonline.be. Last modiﬁed 12 June 2024 7 of 7"
}